A.R.T. Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,272
| Closed | -$62K | – | 1114 |
|
|
2019
Q4 | $62K | Sell |
10,272
-71,100
| -87% | -$429K | ﹤0.01% | 1243 |
|
|
2019
Q3 | $615K | Buy |
+81,372
| New | +$615K | 0.03% | 773 |
|
|
2019
Q2 | – | Sell |
-18,388
| Closed | -$100K | – | 1708 |
|
|
2019
Q1 | $100K | Buy |
18,388
+7,802
| +74% | +$42.4K | 0.01% | 1171 |
|
|
2018
Q4 | $31K | Sell |
10,586
-32,774
| -76% | -$96K | ﹤0.01% | 1235 |
|
|
2018
Q3 | $353K | Buy |
43,360
+26,399
| +156% | +$215K | 0.02% | 982 |
|
|
2018
Q2 | $165K | Sell |
16,961
-69,916
| -80% | -$680K | 0.01% | 1258 |
|
|
2018
Q1 | $754K | Buy |
86,877
+21,879
| +34% | +$190K | 0.03% | 772 |
|
|
2017
Q4 | $813K | Sell |
64,998
-69,125
| -52% | -$865K | 0.04% | 704 |
|
|
2017
Q3 | $1.12M | Buy |
+134,123
| New | +$1.12M | 0.06% | 483 |
|